학술논문
Long-term persistence with evolocumab treatment and sustained reductions in LDL-cholesterol levels over 30 months: Final results from the European observational HEYMANS study
Document Type
Article
Author
Source
In Atherosclerosis February 2023 366:14-21
Subject
Language
ISSN
0021-9150